Table 2 IgG2 and IgG4 isotypes used in therapeutic antibodies on the market or in clinical development As another example, the primatized anti-human CD4 antibody clenoliximab (a stabilized and ...

The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...

EnnoDC presents positive Phase I data at CROI 2025, demonstrating long-lasting immunity induced by Antibody Mediated Vaccines (AMVs)Findings in ...